SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

BRIEF-Eagle Pharmaceuticals Reports Q1 Loss Per Share Of $0.03

05/10/2021 07:45
BRIEF-Eagle Pharmaceuticals Reports Q1 Loss Per Share Of $0.03

- Eagle Pharmaceuticals Inc EGRX.O:

  • EAGLE PHARMACEUTICALS REPORTS FIRST QUARTER 2021 RESULTS

  • Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.24

  • Q1 LOSS PER SHARE $0.03

  • Q1 REVENUE $41.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $45.4 MILLION

  • Q1 EARNINGS PER SHARE ESTIMATE $0.65 -- REFINITIV IBES DATA

  • EXPECTS ABOUT $20-$25 MILLION FROM COMBINED ROYALTY AND MILESTONE REVENUE IN 2022 FOR TREAKISYM

  • QTRLY ADJUSTED NON-GAAP NET INCOME WAS $0.24 PER BASIC AND DILUTED SHARE

Source text for Eikon: ID:nBw4xrwvfa

Further company coverage: EGRX.O


(([email protected];))